Summary
Ikena Oncology is a clinical-stage biotechnology company focused on developing novel, targeted cancer therapies by identifying and inhibiting key signaling pathways and tumor microenvironment modulation that drive cancer growth, spread, and resistance.
Deals Overview
All rights reserved. Copyright © 2025 Datasite
Senior Management
Mark Manfredi
President and CEO
Rebecca Cohen
Head of Investor Relations and Corporate Communications
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy